Why do I have darkening in my skin folds?

Darkening in skin folds (acanthosis nigricans) typically signals insulin resistance, though it can also result from hormonal changes, obesity, or certain medications. Testing blood sugar markers like HbA1c and fasting glucose can help identify underlying metabolic issues requiring treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Skin Darkening in Body Folds

If you've noticed dark, velvety patches of skin in your body folds—such as your neck, armpits, groin, or knuckles—you're not alone. This condition, medically known as acanthosis nigricans, affects millions of people worldwide and often appears as thick, darkened skin that may feel different in texture from the surrounding areas. While these changes might seem purely cosmetic, they frequently signal important underlying health conditions that deserve attention.

The darkening typically develops gradually over months or years, starting as subtle discoloration that progressively becomes more noticeable. Many people initially mistake it for dirt or poor hygiene, leading to vigorous scrubbing that unfortunately won't resolve the issue. Understanding what causes this skin change and what it might indicate about your overall health is crucial for proper management and treatment.

The Science Behind Acanthosis Nigricans

Acanthosis nigricans occurs when skin cells in certain areas multiply faster than normal, leading to thickening and darkening of the skin. This accelerated cell growth is typically triggered by elevated insulin levels in your bloodstream. When insulin levels remain consistently high, they stimulate growth factor receptors in the skin, particularly insulin-like growth factor receptors, causing the characteristic changes in skin appearance and texture.

Acanthosis Nigricans Severity Classification

Severity grading helps track treatment response and may correlate with degree of insulin resistance.
GradeAppearanceTexture ChangesTypical Areas Affected
Grade 1MildBarely visible darkeningMinimal texture changeSingle area (usually neck)
Grade 2ModerateClearly visible brown patchesVelvety texture apparent2-3 areas (neck, armpits)
Grade 3SevereDark brown to blackThick, rough textureMultiple areas including knuckles
Grade 4ExtensiveVery dark, widespreadWarty, papillomatousExtensive involvement, may include palms/soles

Severity grading helps track treatment response and may correlate with degree of insulin resistance.

The condition most commonly affects areas where skin naturally folds or creases, as these regions have higher concentrations of growth factor receptors and experience more friction. The darkening isn't due to increased melanin production like a tan, but rather from the buildup of skin cells (hyperkeratosis) and the proliferation of cells in the upper layers of skin (papillomatosis). Understanding your metabolic health through comprehensive biomarker testing can help identify if insulin resistance is driving these skin changes.

Common Locations and Appearance

The most frequently affected areas include:

  • Neck (especially the back and sides)
  • Armpits (axillae)
  • Groin and inner thighs
  • Knuckles and finger joints
  • Elbows and knees
  • Under the breasts
  • Navel area

The appearance can vary from person to person, but typically presents as brown to black discoloration with a velvety, rough, or warty texture. Some people may also develop small skin tags (acrochordons) in the affected areas.

Primary Causes of Skin Fold Darkening

Insulin Resistance and Metabolic Syndrome

The most common cause of acanthosis nigricans is insulin resistance, a condition where your body's cells don't respond properly to insulin. This forces your pancreas to produce more insulin to maintain normal blood sugar levels. Studies show that up to 74% of obese individuals with acanthosis nigricans have insulin resistance. This connection is so strong that the presence of darkened skin folds is often considered a clinical marker for metabolic dysfunction.

Insulin resistance doesn't just affect your skin—it's a precursor to type 2 diabetes and is associated with metabolic syndrome, a cluster of conditions including high blood pressure, abnormal cholesterol levels, and excess abdominal fat. If you notice skin darkening along with symptoms like increased thirst, frequent urination, or unexplained weight changes, it's essential to get your metabolic markers tested promptly.

Hormonal Imbalances

Several hormonal conditions can trigger acanthosis nigricans:

  • Polycystic Ovary Syndrome (PCOS): Affects up to 10% of women of reproductive age and commonly causes both insulin resistance and skin darkening
  • Thyroid disorders: Both hypothyroidism and hyperthyroidism can contribute to skin changes
  • Cushing's syndrome: Excess cortisol production can lead to insulin resistance and subsequent skin darkening
  • Growth hormone excess: Conditions like acromegaly can stimulate skin cell proliferation
  • Addison's disease: Though less common, adrenal insufficiency can cause hyperpigmentation

For individuals experiencing hormonal symptoms alongside skin changes, comprehensive hormone testing can provide valuable insights into underlying imbalances that may be contributing to both issues.

Obesity and Genetic Factors

Obesity independently increases the risk of developing acanthosis nigricans, even in the absence of diabetes. The condition affects up to 66% of children and adults who are significantly overweight. This association likely relates to the complex relationship between adipose tissue, insulin signaling, and inflammatory processes. Additionally, certain genetic variations can predispose individuals to developing the condition, with some families showing clear hereditary patterns of benign acanthosis nigricans that may appear in childhood or adolescence.

Less Common but Important Causes

While metabolic and hormonal causes are most frequent, several other factors can contribute to skin fold darkening:

  • Medications: Certain drugs including high-dose niacin, oral contraceptives, corticosteroids, and some psychiatric medications can trigger skin changes
  • Malignancy: In rare cases (malignant acanthosis nigricans), sudden onset of extensive skin darkening can signal internal cancer, particularly gastric adenocarcinoma
  • Autoimmune conditions: Some autoimmune disorders can cause similar skin changes
  • Friction and irritation: Chronic rubbing from tight clothing or skin-on-skin contact can cause post-inflammatory hyperpigmentation
  • Infections: Certain bacterial or fungal infections in skin folds can lead to darkening

The sudden appearance of widespread acanthosis nigricans in adults over 40, especially if accompanied by unexplained weight loss or other systemic symptoms, warrants immediate medical evaluation to rule out underlying malignancy.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approach and Testing

Proper diagnosis of acanthosis nigricans and its underlying cause requires a comprehensive approach. Your healthcare provider will typically begin with a thorough medical history and physical examination, paying particular attention to the distribution and characteristics of the skin changes. They'll also assess for other signs of insulin resistance or hormonal imbalances, such as skin tags, hirsutism (excess hair growth), or abdominal obesity.

Essential Laboratory Tests

Key biomarkers to evaluate include:

  • Fasting glucose and HbA1c: To assess blood sugar control and screen for diabetes
  • Fasting insulin and C-peptide: To evaluate insulin resistance directly
  • Lipid panel: Including triglycerides and HDL cholesterol, often abnormal in metabolic syndrome
  • Thyroid function tests (TSH, Free T3, Free T4): To rule out thyroid disorders
  • Hormone panels: Including testosterone, DHEA-S, and cortisol levels
  • For women: LH, FSH, and anti-Müllerian hormone to evaluate for PCOS

Regular monitoring of these biomarkers can help track your metabolic health and the effectiveness of any interventions. For a convenient way to check these markers from home, consider comprehensive testing that includes both metabolic and hormonal assessments.

Treatment Strategies and Management

Addressing Underlying Conditions

The most effective approach to treating acanthosis nigricans involves addressing its root cause. For insulin resistance, this typically includes:

  • Weight loss: Even a 5-10% reduction in body weight can significantly improve insulin sensitivity and skin appearance
  • Dietary modifications: Following a low-glycemic diet that minimizes blood sugar spikes
  • Regular exercise: Both aerobic and resistance training improve insulin sensitivity
  • Medications: Metformin is commonly prescribed to improve insulin sensitivity
  • For PCOS: Combination therapy may include hormonal contraceptives and anti-androgen medications

Topical and Cosmetic Treatments

While addressing the underlying cause is paramount, several topical treatments can help improve skin appearance:

  • Retinoids (tretinoin, adapalene): Help normalize skin cell turnover
  • Chemical exfoliants (salicylic acid, glycolic acid): Remove excess dead skin cells
  • Vitamin D analogs (calcipotriol): May help reduce skin thickening
  • Lightening agents (hydroquinone, kojic acid): Can help with pigmentation
  • Laser therapy: For resistant cases, various laser treatments can improve skin texture and color

It's important to note that topical treatments alone rarely provide complete resolution without addressing the underlying metabolic or hormonal issues. Combining medical treatment with regular monitoring of your health markers provides the best outcomes.

Prevention and Long-term Management

Preventing acanthosis nigricans or its recurrence focuses on maintaining optimal metabolic health:

  • Maintain a healthy weight through balanced nutrition and regular physical activity
  • Monitor blood sugar levels regularly, especially if you have risk factors for diabetes
  • Manage stress through techniques like meditation, yoga, or counseling
  • Ensure adequate sleep (7-9 hours nightly) to support hormonal balance
  • Avoid medications known to trigger the condition when possible
  • Keep skin folds clean and dry to prevent secondary infections
  • Wear loose-fitting clothing to minimize friction in affected areas

For those already diagnosed with acanthosis nigricans, regular follow-up with healthcare providers is essential. This includes periodic testing of metabolic markers, adjustment of treatments as needed, and screening for potential complications of underlying conditions like diabetes or PCOS.

If you're concerned about skin changes or want to understand your metabolic health better, consider uploading your existing blood test results for a comprehensive analysis. SiPhox Health's free upload service can help you interpret your biomarkers and provide personalized recommendations based on your unique health profile.

Taking Action for Your Health

Darkening in skin folds might seem like a minor cosmetic concern, but it often represents an important window into your metabolic health. By recognizing acanthosis nigricans as a potential sign of insulin resistance or other hormonal imbalances, you can take proactive steps to address underlying health issues before they progress to more serious conditions like type 2 diabetes or cardiovascular disease.

Remember that improvement takes time—skin changes typically lag behind metabolic improvements by several months. Stay consistent with treatment, maintain regular monitoring of your health markers, and work closely with your healthcare team to achieve the best possible outcomes. With proper management of underlying conditions, many people see significant improvement or complete resolution of their skin darkening, along with better overall health and well-being.

References

  1. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5(3):239-249.[Link][PubMed][DOI]
  2. Popa ML, Popa AC, Tanase C, Gheorghisan-Galateanu AA. Acanthosis nigricans: To be or not to be afraid. Oncol Lett. 2019;17(5):4133-4138.[Link][PubMed][DOI]
  3. Kutlubay Z, Engin B, Bairamov O, Tüzün Y. Acanthosis nigricans: A fold (intertriginous) dermatosis. Clin Dermatol. 2015;33(4):466-470.[Link][PubMed][DOI]
  4. Ng HY. Acanthosis nigricans in obese adolescents: prevalence, impact, and management challenges. Adolesc Health Med Ther. 2017;8:1-10.[Link][PubMed][DOI]
  5. Das A, Datta D, Kassir M, et al. Acanthosis nigricans: A review. J Cosmet Dermatol. 2020;19(8):1857-1865.[Link][PubMed][DOI]
  6. Bubna AK. Acanthosis nigricans: An extensive review. Our Dermatol Online. 2021;12(3):311-318.[DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my insulin and glucose levels at home?

You can test your insulin and glucose levels at home with SiPhox Health's Heart & Metabolic Program, which includes HbA1c and C-peptide testing to assess insulin resistance and blood sugar control. The program provides lab-quality results from the comfort of your home.

Is skin darkening in folds always a sign of diabetes?

No, while acanthosis nigricans is strongly associated with insulin resistance and prediabetes, it doesn't always indicate diabetes. It can also result from hormonal conditions like PCOS, thyroid disorders, obesity, certain medications, or genetic factors. However, it's important to get tested to rule out metabolic issues.

Can the dark patches go away completely?

Yes, acanthosis nigricans can improve significantly or resolve completely when the underlying cause is treated. Weight loss, improved insulin sensitivity, and hormonal balance can lead to gradual lightening of the affected areas, though skin changes typically take several months to improve after metabolic health improves.

What's the difference between acanthosis nigricans and regular hyperpigmentation?

Acanthosis nigricans has a distinctive velvety, thickened texture and appears specifically in body folds, while regular hyperpigmentation is typically flat and can occur anywhere. Acanthosis nigricans is caused by skin cell overgrowth due to high insulin levels, whereas regular hyperpigmentation results from excess melanin production.

Should I see a dermatologist or an endocrinologist?

Both specialists can be helpful. A dermatologist can diagnose the skin condition and provide topical treatments, while an endocrinologist can evaluate and treat underlying metabolic or hormonal causes. Many people benefit from seeing both, starting with their primary care physician for initial evaluation and blood work.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details